日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SAT-796 REMS Suitability in Endocrine-Related Bone Disorders

SAT-796 REMS 在内分泌相关骨骼疾病中的适用性

Andersen, Courtney L; Sikora, Matthew J; Boisen, Michelle M; Ma, Tianzhou; Christie, Alec; Tseng, George; Park, Yongseok; Luthra, Soumya; Chandran, Uma; Haluska, Paul; Mantia-Smaldone, Gina M; Odunsi, Kunle; McLean, Karen; Lee, Adrian V; Elishaev, Esther; Edwards, Robert P; Oesterreich, Steffi; Luna, Eduardo Dusty

Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies

一项针对晚期实体恶性肿瘤患者的 I 期研究,评估了口服 VEGFR 抑制剂 cediranib 与口服 MEK 抑制剂 selumetinib 联合用药的疗效。

Hubbard, Joleen M; Yin, Jun; Schenk, Erin L; Qin, Rui; Reid, Joel M; Strand, Carrie; Fiskum, Jack; Menefee, Michael; Lin, Grace; Doyle, L Austin; Ivy, Percy; Erlichman, Charles; Adjei, Alex; Haluska, Paul; Costello, Brian A

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

加尼妥单抗和二甲双胍联合标准新辅助疗法用于 2/3 期乳腺癌

Yee, Douglas; Isaacs, Claudine; Wolf, Denise M; Yau, Christina; Haluska, Paul; Giridhar, Karthik V; Forero-Torres, Andres; Jo Chien, A; Wallace, Anne M; Pusztai, Lajos; Albain, Kathy S; Ellis, Erin D; Beckwith, Heather; Haley, Barbara B; Elias, Anthony D; Boughey, Judy C; Kemmer, Kathleen; Yung, Rachel L; Pohlmann, Paula R; Tripathy, Debu; Clark, Amy S; Han, Hyo S; Nanda, Rita; Khan, Qamar J; Edmiston, Kristen K; Petricoin, Emanuel F; Stringer-Reasor, Erica; Falkson, Carla I; Majure, Melanie; Mukhtar, Rita A; Helsten, Teresa L; Moulder, Stacy L; Robinson, Patricia A; Wulfkuhle, Julia D; Brown-Swigart, Lamorna; Buxton, Meredith; Clennell, Julia L; Paoloni, Melissa; Sanil, Ashish; Berry, Scott; Asare, Smita M; Wilson, Amy; Hirst, Gillian L; Singhrao, Ruby; Asare, Adam L; Matthews, Jeffrey B; Hylton, Nola M; DeMichele, Angela; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope S; Fraser Symmans, W; Van't Veer, Laura J; Berry, Donald A; Esserman, Laura J

Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)

卡培他滨和拉帕替尼联合或不联合IMC-A12(西妥昔单抗)治疗既往接受过曲妥珠单抗和化疗的HER2阳性晚期乳腺癌患者的随机II期试验:NCCTG N0733(Alliance)

Haddad, Tufia C; He, Jun; O'Sullivan, Ciara C; Chen, Beiyun; Northfelt, Donald; Dueck, Amylou C; Ballman, Karla V; Tenner, Kathleen S; Linden, Hannah; Sparano, Joseph A; Hopkins, Judith O; De Silva, Chamath; Perez, Edith A; Haluska, Paul; Goetz, Matthew P

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

高级别浆液性卵巢癌分子亚型基因表达预测因子(PrOTYPE)的开发与验证

Talhouk, Aline; George, Joshy; Wang, Chen; Budden, Timothy; Tan, Tuan Zea; Chiu, Derek S; Kommoss, Stefan; Leong, Huei San; Chen, Stephanie; Intermaggio, Maria P; Gilks, Blake; Nazeran, Tayyebeh M; Volchek, Mila; Elatre, Wafaa; Bentley, Rex C; Senz, Janine; Lum, Amy; Chow, Veronica; Sudderuddin, Hanwei; Mackenzie, Robertson; Leong, Samuel C Y; Liu, Geyi; Johnson, Dustin; Chen, Billy; Group, Aocs; Alsop, Jennifer; Banerjee, Susana N; Behrens, Sabine; Bodelon, Clara; Brand, Alison H; Brinton, Louise; Carney, Michael E; Chiew, Yoke-Eng; Cushing-Haugen, Kara L; Cybulski, Cezary; Ennis, Darren; Fereday, Sian; Fortner, Renée T; García-Donas, Jesús; Gentry-Maharaj, Aleksandra; Glasspool, Rosalind; Goranova, Teodora; Greene, Casey S; Haluska, Paul; Harris, Holly R; Hendley, Joy; Hernandez, Brenda Y; Herpel, Esther; Jimenez-Linan, Mercedes; Karpinskyj, Chloe; Kaufmann, Scott H; Keeney, Gary L; Kennedy, Catherine J; Köbel, Martin; Koziak, Jennifer M; Larson, Melissa C; Lester, Jenny; Lewsley, Liz-Anne; Lissowska, Jolanta; Lubiński, Jan; Luk, Hugh; Macintyre, Geoff; Mahner, Sven; McNeish, Iain A; Menkiszak, Janusz; Nevins, Nikilyn; Osorio, Ana; Oszurek, Oleg; Palacios, José; Hinsley, Samantha; Pearce, Celeste L; Pike, Malcolm C; Piskorz, Anna M; Ray-Coquard, Isabelle; Rhenius, Valerie; Rodriguez-Antona, Cristina; Sharma, Raghwa; Sherman, Mark E; De Silva, Dilrini; Singh, Naveena; Sinn, Peter; Slamon, Dennis; Song, Honglin; Steed, Helen; Stronach, Euan A; Thompson, Pamela J; Tołoczko, Aleksandra; Trabert, Britton; Traficante, Nadia; Tseng, Chiu-Chen; Widschwendter, Martin; Wilkens, Lynne R; Winham, Stacey J; Winterhoff, Boris; Beeghly-Fadiel, Alicia; Benitez, Javier; Berchuck, Andrew; Brenton, James D; Brown, Robert; Chang-Claude, Jenny; Chenevix-Trench, Georgia; deFazio, Anna; Fasching, Peter A; García, María J; Gayther, Simon A; Goodman, Marc T; Gronwald, Jacek; Henderson, Michelle J; Karlan, Beth Y; Kelemen, Linda E; Menon, Usha; Orsulic, Sandra; Pharoah, Paul D P; Wentzensen, Nicolas; Wu, Anna H; Schildkraut, Joellen M; Rossing, Mary Anne; Konecny, Gottfried E; Huntsman, David G; Huang, Ruby Yun-Ju; Goode, Ellen L; Ramus, Susan J; Doherty, Jennifer A; Bowtell, David D; Anglesio, Michael S

Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study

罗米地辛治疗癌症合并肝功能障碍患者的I期临床试验及药代动力学研究:美国国家癌症研究所器官功能障碍工作组研究

Connolly, Roisin M; Laille, Eric; Vaishampayan, Ulka; Chung, Vincent; Kelly, Karen; Dowlati, Afshin; Alese, Olatunji B; Harvey, R Donald; Haluska, Paul; Siu, Lillian L; Kummar, Shivaani; Piekarz, Richard; Ivy, S Percy; Anders, Nicole M; Downs, Melinda; O'Connor, Ashley; Scardina, Angela; Saunders, Jacqueline; Rosner, Gary L; Carducci, Michael A; Rudek, Michelle A

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

维莫德吉联合厄洛替尼治疗转移性胰腺癌的I期临床试验

McCleary-Wheeler, Angela L; Carr, Ryan M; Palmer, Shanique R; Smyrk, Thomas C; Allred, Jacob B; Almada, Luciana L; Tolosa, Ezequiel J; Lamberti, Maria J; Marks, David L; Borad, Mitesh J; Molina, Julian R; Qi, Yingwei; Lingle, Wilma L; Grothey, Axel; Pitot, Henry C; Jatoi, Aminah; Northfelt, Donald W; Bryce, Alan H; McWilliams, Robert R; Okuno, Scott H; Haluska, Paul; Kim, George P; Colon-Otero, Gerardo; Lowe, Val J; Callstrom, Matthew R; Ma, Wen We; Bekaii-Saab, Tanios; Hung, Mien-Chie; Erlichman, Charles; Fernandez-Zapico, Martin E

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

一项针对实体瘤患者的聚(ADP-核糖)聚合酶抑制剂维利帕尼联合每周一次拓扑替康的I期临床试验

Wahner Hendrickson, Andrea E; Menefee, Michael E; Hartmann, Lynn C; Long, Harry J; Northfelt, Donald W; Reid, Joel M; Boakye-Agyeman, Felix; Kayode, Olumide; Flatten, Karen S; Harrell, Maria I; Swisher, Elizabeth M; Poirier, Guy G; Satele, Daniel; Allred, Jake; Lensing, Janet L; Chen, Alice; Ji, Jiuping; Zang, Yiping; Erlichman, Charles; Haluska, Paul; Kaufmann, Scott H

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes

常见和罕见上皮性卵巢癌组织学亚型中融合基因的特征分析

Earp, Madalene A; Raghavan, Rama; Li, Qian; Dai, Junqiang; Winham, Stacey J; Cunningham, Julie M; Natanzon, Yanina; Kalli, Kimberly R; Hou, Xiaonan; Weroha, S John; Haluska, Paul; Lawrenson, Kate; Gayther, Simon A; Wang, Chen; Goode, Ellen L; Fridley, Brooke L

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma

PARP抑制剂尼拉帕尼在同源重组缺陷型和功能型卵巢癌中的体内抗肿瘤活性

AlHilli, Mariam M; Becker, Marc A; Weroha, S John; Flatten, Karen S; Hurley, Rachel M; Harrell, Maria I; Oberg, Ann L; Maurer, Matt J; Hawthorne, Kieran M; Hou, Xiaonan; Harrington, Sean C; McKinstry, Sarah; Meng, X Wei; Wilcoxen, Keith M; Kalli, Kimberly R; Swisher, Elizabeth M; Kaufmann, Scott H; Haluska, Paul